Top stories
Marketing & MediaCycle for Change campaign sets a high standard for purpose-led brand investment
MANGO-OMC 2 days
Marketing & MediaRegister for the CMO Summit, free tickets available to Biz readers
Bizcommunity.com 27 Aug 2025
More news
Subscribe & Follow
Advertise your job vacancies
Jobs
- Junior Graphic Designer Johannesburg
- PackMark / PackWorx Workshop Assistant Cape Town
- R&D Manager Cape Town
- Production Coordinator / Assistant Production Manager Johannesburg
- DTP Operator/Pre-Press Operator Benoni
- Junior Bookkeeper/Accounts Clerk/Estimator Cape Town
- External Sales Representative Vereeniging
- Electronic Workshop Technician Vereeniging
- Electrician Johannesburg
- External Sales Representative - Exports (Africa region) Vereeniging
Govt awards antiretroviral tender to Cipla
JSE-listed pharmaceutical company, Cipla Medpro SA, announced in a press release that it has been awarded an antiretroviral (ARV) tender from government worth a combined value of approximately R1.448b for a two year period commencing 1 January 2013, Health24 reports.
This more than doubles on the company's 2010 to 2012 ARV R633m tender. Altogether, tender business between the government and Cipla Medpro will exceed R2bn for the next two years.
Cipla Medpro SA Deputy CEO, Dr Skhumbuzo Ngozwana, believes that the company, in partnership with government and other stakeholders, will play a significant role in contributing to the decrease of HIV infections across the country through "patient education, training healthcare workers to enable them to deliver better care and (providing) high quality, affordable medicines to prevent and treat HIV/AIDS infections."
The tender will procure ARV treatment for what is now the world's largest HIV treatment programme, with over 1.7 million people on treatment in South Africa Health24 reports.
Read the full article on www.health24.com.
